Our platform exposes secrets hiding in the options market. Unusual options activity tracking to catch where the smart money is quietly positioning. Hidden bets and sentiment indicators that precede major price moves.
Serina Therapeutics Inc. (SER), a clinical-stage biotechnology company focused on the development of novel polymer-based drug delivery technologies, experienced a modest decline in recent trading sessions. The stock traded at $1.75 per share, reflecting a decrease of approximately 3.31% during the period under review. This pullback places the shares within a well-defined trading range, with key technical levels drawing attention from market participants. The biotechnology sector has demonstrated
How Serina Therapeutics (SER) responds when competition intensifies (Volatility Increases) 2026-05-08 - Call Flow Alert
SER - Stock Analysis
3608 Comments
1905 Likes
1
Antinique
Trusted Reader
2 hours ago
I understood nothing but nodded anyway.
👍 36
Reply
2
Pharrah
Engaged Reader
5 hours ago
Every step reflects careful thought.
👍 283
Reply
3
Ace
Elite Member
1 day ago
Short-term trading requires attention to both technical indicators and news catalysts.
👍 196
Reply
4
Abdiel
Returning User
1 day ago
I should’ve double-checked before acting.
👍 292
Reply
5
Heston
Insight Reader
2 days ago
Free US stock market sentiment analysis and institutional activity tracking to understand what smart money is doing in the market. Our tools reveal buying and selling patterns of large institutional investors who often move stock prices significantly. We provide 13F filing analysis, options flow data, and sector rotation indicators for comprehensive market intelligence. Follow the money and make smarter investment decisions with our comprehensive sentiment analysis and institutional tracking tools.
👍 195
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.